Company News

Anti-Aging, Photodamage Propel Prescription Derm Products Sector

Prescription dermatological products reached $23.4 billion in 2016, growing at a rate of 9.3%.

Author Image

By: Christine Esposito

Editor-in-Chief

The worldwide market for prescription dermatological products reached $23.4 billion in 2016, growing at a rate of 9.3% from 2014 to 2016, according to Kalorama Information.  The New York City-based market research firm said that is five times revenue growth of industry.  The antiaging and photodamage, psoriasis, and skin cancer treatments dermatology drug sectors showed the most dramatic gains.  Sales of prescription acne and rosacea, dermatitis and seborrhea, fungal infection, hair loss/removal...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters